Bharat Biotech keen to invest in K’taka, Krishna Ella meets minister Nirani

BENGALURU: Bharat Biotech chairman and managing director Dr Krishna M Ella met Large and Medium Industries Minister D. Murugesh Nirani in Hyderabad on Friday and evinced interest in investing in Karnataka.

Bharat Biotech produces Covaxin, the Covid-19 vaccination, among other drugs.

Ella, however, did not divulge the details or nature and extent of investment and said that he will soon come out with an investment plan.

In a meeting held at a private hotel as a part of roadshow for the Global Investors’ Meet (GIM), scheduled on November 2-4 in Bengaluru, Dr Nirani appraised Dr Ella about the potential and advantages in investing in Karnataka.

Bharat Biotech has evinced interest to invest in Karnataka.

“Karnataka is committed to facilitating ease of doing business and will provide all support and infrastructure facilities to the investors in the state,” he said.

The minister also invited Dr Ella to the Global Investors Meet. “There is an intention to invest in Karnataka, where the industrial environment is favourable for business,” said the Bharat Biotech chief.

Additional Chief Secretary, Department of Commerce and Industry, Dr E V Raman Reddy, Industrial Development Commissioner Gunjan Krishna, and other senior officers participated in the meeting.

Nirani also met several other investors in Hyderabad. The department will conduct an investors’ roadshow in Mumbai on October 19.